Pactiv Evergreen Inc. (NASDAQ:PTVE) Receives $10.60 Consensus Price Target from Analysts
Pactiv Evergreen Inc. (NASDAQ:PTVE – Get Free Report) has been given a consensus rating of “Buy” by the five research firms that are covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have issued a report on the stock in […]
More Stories
ServiceNow, Inc. (NYSE:NOW) Receives $1,062.50 Average Price Target from Brokerages
Shares of ServiceNow, Inc. (NYSE:NOW – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the...
Analysts Set NovoCure Limited (NASDAQ:NVCR) Target Price at $32.83
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six analysts that...
OFA Group (NASDAQ:OFAL) Upgraded by Wall Street Zen to “Hold” Rating
OFA Group (NASDAQ:OFAL – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “hold” rating...
Cantor Fitzgerald Upgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to “Strong-Buy”
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in...
Micron Technology (NASDAQ:MU) Stock Price Up 4.3% After Analyst Upgrade
Micron Technology, Inc. (NASDAQ:MU – Get Free Report)’s share price shot up 4.3% during trading on Friday after Mizuho raised...
Wall Street Zen Downgrades Complete Solaria (NASDAQ:SPWR) to Hold
Complete Solaria (NASDAQ:SPWR – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to...